VICINIUM Trademark

Trademark Overview

On Thursday, April 1, 2004, a trademark application was filed for VICINIUM with the United States Patent and Trademark Office. The USPTO has given the VICINIUM trademark a serial number of 78394619. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 8, 2014. This trademark is owned by Viventia Biotech Inc.. The VICINIUM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biotechnology products, namely, therapeutic anti-cancer drugs
vicinium

General Information

Serial Number78394619
Word MarkVICINIUM
Filing DateThursday, April 1, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 8, 2014
Registration Number3363110
Registration DateTuesday, January 1, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 18, 2005

Trademark Statements

Goods and ServicesPharmaceutical and biotechnology products, namely, therapeutic anti-cancer drugs

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 8, 2014
Primary Code005
First Use Anywhere DateSaturday, March 31, 2007
First Use In Commerce DateSaturday, March 31, 2007

Trademark Owner History

Party NameVIVENTIA BIOTECHNOLOGIES INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMISSISSAUGA, ONTARIO L5S 1V9
CA
Party NameViventia Biotech Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L4W 5N5
CA
Party NameViventia Biotech Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L4W 5N5
CA
Party NameViventia Biotech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9B 6H7
CA

Trademark Events

Event DateEvent Description
Friday, August 8, 2014CANCELLED SEC. 8 (6-YR)
Wednesday, August 31, 2011AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 1, 2008REGISTERED-PRINCIPAL REGISTER
Wednesday, November 28, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, November 28, 2007ASSIGNED TO LIE
Thursday, October 25, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 12, 2007TEAS EXTENSION RECEIVED
Tuesday, October 9, 2007STATEMENT OF USE PROCESSING COMPLETE
Friday, September 21, 2007USE AMENDMENT FILED
Friday, September 21, 2007PAPER RECEIVED
Thursday, August 16, 2007EXTENSION 4 GRANTED
Monday, March 26, 2007EXTENSION 4 FILED
Monday, March 26, 2007TEAS EXTENSION RECEIVED
Wednesday, November 1, 2006EXTENSION 3 GRANTED
Friday, September 29, 2006EXTENSION 3 FILED
Friday, September 29, 2006TEAS EXTENSION RECEIVED
Friday, April 21, 2006EXTENSION 2 GRANTED
Friday, April 7, 2006EXTENSION 2 FILED
Monday, April 17, 2006ASSIGNED TO EXAMINER
Friday, April 7, 2006TEAS EXTENSION RECEIVED
Wednesday, February 16, 2005ASSIGNED TO EXAMINER
Wednesday, February 15, 2006ASSIGNED TO EXAMINER
Friday, October 21, 2005EXTENSION 1 GRANTED
Monday, October 3, 2005EXTENSION 1 FILED
Monday, October 3, 2005TEAS EXTENSION RECEIVED
Thursday, June 16, 2005APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 31, 2005PAPER RECEIVED
Tuesday, April 12, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 18, 2005PUBLISHED FOR OPPOSITION
Wednesday, December 29, 2004NOTICE OF PUBLICATION
Friday, November 19, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, November 19, 2004ASSIGNED TO LIE
Friday, November 19, 2004ASSIGNED TO LIE
Monday, November 1, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 21, 2004EXAMINERS AMENDMENT E-MAILED
Thursday, October 21, 2004EXAMINERS AMENDMENT -WRITTEN
Thursday, October 21, 2004ASSIGNED TO EXAMINER
Friday, April 9, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

vicinium anti cancer drugs therapeutic namely biotechnology products pharmaceutical